Füzi, Barbara
Malik-Sheriff, Rahuman S.
Manners, Emma J.
Hermjakob, Henning
Ecker, Gerhard F. https://orcid.org/0000-0003-4209-6883
Funding for this research was provided by:
Innovative Medicines Initiative 2 (116030)
European Union’s Horizon 2020 Research and Innovation Programme (116030)
European Federation of Pharmaceutical Industries and Associations (116030)
Austrian Science Fund/FWF (W1232)
EMBL core funding
Wellcome Trust (104104/A/14/Z, 218244/Z/19/Z)
Member States of the European Molecular Biology Laboratory
Article History
Received: 27 December 2021
Accepted: 21 May 2022
First Online: 13 June 2022
Declarations
:
: The Authors declare no competing interests.